Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer

Journal of Medical Imaging and Radiation Oncology

Volumn 54, Issue 3, 2010, Pages 178-187

  Wang, S C ^a   Bester, L ^b   Burnes, J P ^c   Clouston, J E ^d   Hugh, T J ^e   Little, A F ^f   Padbury, R T A ^g   Price, D ^h  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d WESLEY HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f CABRINI HOSPITAL   (Australia)

^g FLINDERS MEDICAL CENTRE   (Australia)

^h Mount Medical Centre   (Australia)

Author keywords

Antineoplastic protocols; Interventional radiology; Liver neoplasms; Microspheres; Yttrium radioisotopes

Indexed keywords

MICROSPHERE; SIR SPHERES; THERASPHERE; UNCLASSIFIED DRUG; YTTRIUM 90;

ARTERY CATHETERIZATION; ARTIFICIAL EMBOLISM; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CHOLECYSTITIS; CLINICAL COMPETENCE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; DOSIMETRY; DRUG DELIVERY SYSTEM; HEPATIC ARTERY; HUMAN; LIVER ANGIOGRAPHY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION CHOLECYSTITIS; RADIATION INJURY; REVIEW; SELECTIVE INTERNAL RADIATION THERAPY; STOMACH ULCER;

BRACHYTHERAPY; HUMANS; LIVER NEOPLASMS; RADIOGRAPHY, INTERVENTIONAL; RADIOPHARMACEUTICALS; YTTRIUM RADIOISOTOPES;

EID: 77953547030     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2010.02167.x     Document Type: Review

References (40)

1. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 3: comprehensive literature review and future direction. J Vasc Interv Radiol 2006 17: 1571 1594.
2. Sirtex Medical. SIR-Spheres® Microspheres Package Insert. Sirtex Medical Limited
3. 90Y-microsphere brachytherapy is effective in treating unresectable colorectal liver metastases. Am J Hematol Oncol 2006 5: 1 5.
4. 90Y Microspheres. Springer-Verlag
5. 90Y Microspheres. Springer-Verlag
6. 90Y Microspheres. Springer-Verlag
7. Liu DM, Salem R, Bui JT et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 2005 16: 911 935.
8. Van Hazel G, Blackwell A, Anderson J et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004 88: 78 85.
9. Vente M, Wondergem M, van der Tweel I et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol 2008 19: 951 959.
10. 90Y- microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 2009 74: 1494 1500.
11. 90Y Microspheres. Springer-Verlag
12. 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 2006 17: 1425 1439. (Pubitemid 44412994)
13. Murthy R, Brown DB, Salem R et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007 18: 553 561.
14. 90yttrium- microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995 33: 919 924.
15. Sangro B, Gil-Alzugaray B, Rodriguez J et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 2008 112: 1538 1546.
16. Gaba RC, Lewandowski RJ, Kulik LM et al. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol 2009 16: 1587 1596.
17. Kennedy A, Nag S, Salem R et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007 68: 13 23.
18. Dezarn WA. Quality assurance issues for therapeutic application of radioactive microspheres. Int J Radiat Oncol Biol Phys 2008 71 (Suppl 1 S147 51.
19. Sirtex Medical. SIR-Spheres® Training Program: Physicians and Institutions. Sirtex Medical
20. 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations. J Vasc Interv Radiol 2006 17: 1251 1278. (Pubitemid 44259009)
21. Murthy R, Nunez R, Szklaruk J et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 2005 2S: S41 55.
22. 90Y Microspheres. Springer-Verlag
23. Kim HC, Chung JW, Lee W, Jae HJ, Park JH. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 2005 25 (Suppl 1 S25 39.
24. Siddiqi NH, Devlin PM. Radiation lobectomy-a minimally invasive treatment model for liver cancer: case report. J Vasc Interv Radiol 2009 20: 664 669.
25. 90Y Microspheres. Springer-Verlag
26. 90Y Microspheres. Springer-Verlag
27. m macroaggregated albumin. Br J Radiol 1997 70: 823 828.
28. Gulec SA, Mesoloras G, Dezarn WA, McNeillie P, Kennedy AS. Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio. J Transl Med serial on the Internet 2007 5 Cited 10 March 2009.] Available from URL: http://www.translational-medicine.com/content/5/1/15
29. Lau WY, Leung WT, Ho S et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 1994 70: 994 999.
30. Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997 24: 293 298.
31. Gray BN, Burton MA, Kelleher D, Klemp P, Matz L. Tolerance of the liver to the effects of yttrium-90 radiation. Int J Radiat Oncol Biol Phys 1990 18: 619 623.
32. Young JY, Rhee TK, Atassi B et al. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol 2007 18: 1375 1382.
33. Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2001 46: 487 498.
34. Burton MA, Gray BN, Klemp PF, Kelleher DK, Hardy N. Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol 1989 25: 1487 1491.
35. 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med 2006 47: 1209 1211.
36. Thamboo TP, Wai CT, Lim LG, Wang S-C. Late gastric ulceration and cytomegalovirus infection following selective internal radiation therapy (SIRT) of the liver. Pathology (Phila) 2008 40: 303 305.
37. South C, Meyer M, Meis G et al. Yttrium-90 microsphere induced gastrointestinal tract ulceration. World J Surg Oncol Serial on the Internet 2008 6 Cited 11 March 2009.] Available from URL: http://www.wjso.com/content/6/ 1/93
38. Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 2008 64: 935 951.
39. 18F-FDG uptake and tumour size on PET/CT. Eur J Nucl Med Mol Imaging 2005 32: 778 787.
40. 90Y microsphere brachytherapy: a new standard for oncologic response assessment? Am J Roentgenol 2007 188: 765 767.